Breaking News Instant updates and real-time market news.

BHVN

Biohaven Pharmaceutical

$57.33

-5.63 (-8.94%)

18:12
06/17/19
06/17
18:12
06/17/19
18:12

Biohaven Pharmaceutical down 20% to $45.94 after $300M offering of common stock

BHVN Biohaven Pharmaceutical
$57.33

-5.63 (-8.94%)

05/06/19
GSCO
05/06/19
INITIATION
Target $92
GSCO
Buy
Biohaven Pharmaceutical initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Paul Choi started Biohaven Pharmaceutical with a Buy rating and $92 price target. The analyst believes Biohaven will become a "more significant presence in the attractive" calcitonin gene-related peptide/migraine space than is currently priced into the shares. Rimegepant's profile can drive above consensus sales on conservative patient numbers, Choi tells investors in a research note.
05/08/19
PIPR
05/08/19
NO CHANGE
Target $100
PIPR
Overweight
Biohaven Pharmaceutical price target raised to $100 from $75 at Piper Jaffray
Piper Jaffray analyst Tyler Van Buren raised his price target for Biohaven Pharmaceutical to $100 from $75 saying key opinion feedback suggests rimegepant is "unequivocally best-in-class and is exceptionally clean." The analyst sees it as highly unlikely that the pivotal prevention trial won't be successful in Q4. He keeps an Overweight rating on Biohaven shares.
05/08/19
NEED
05/08/19
NO CHANGE
Target $70
NEED
Buy
Biohaven Pharmaceutical price target raised to $70 from $56 at Needham
Needham analyst Alan Carr raised his price target on Biohaven Pharmaceutical to $70 and kept his Buy rating after its Q1 results and updated progress on its glutamate modulating platform. The analyst anticipates approval of the company's Nurtec for ALS by July 2019 PDUFA date with $24M in peak sales modeled for the program and also cites migraine platform expansion with the start of Phase 2/3 trial of intranasal BHV-3500 in Acute Migraine in April.
06/17/19
ADAM
06/17/19
NO CHANGE
Target $89
ADAM
Buy
Biohaven unaware of news to account for weakness, says Canaccord
Canaccord analyst Sumant Kulkarni noted that Biohaven Pharmaceutical shares are down 12% today despite any specific news that can explain the weakness, "other than there being no news" after the company recently cancelled from an investor conference. Biohaven management confirmed to him that there has been no news, stating if the company's stated timeline for a new drug application filing on rimegepant for the acute treatment of migraine were to change it would let investors know and if for some reason it received a non-acceptance from the FDA an investor update would be necessary. Kulkarni keeps a Buy rating and $89 price target on Biohaven shares.

TODAY'S FREE FLY STORIES

COT

Cott Corp.

$12.34

0.05 (0.41%)

20:29
07/23/19
07/23
20:29
07/23/19
20:29
Upgrade
Cott Corp. rating change at Goldman Sachs »

Cott Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 25

    Sep

20:25
07/23/19
07/23
20:25
07/23/19
20:25
Conference/Events
CLSA Asian tech analysts to hold an analyst/industry conference call »

Asian Technology Analysts…

T

AT&T

$32.09

-0.05 (-0.16%)

, BA

Boeing

$372.91

-0.48 (-0.13%)

20:25
07/23/19
07/23
20:25
07/23/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

T

AT&T

$32.09

-0.05 (-0.16%)

BA

Boeing

$372.91

-0.48 (-0.13%)

TMO

Thermo Fisher

$293.82

2.07 (0.71%)

NEE

NextEra Energy

$207.31

-2.05 (-0.98%)

UPS

UPS

$105.24

1.25 (1.20%)

ANTM

Anthem

$302.82

1.04 (0.34%)

CAT

Caterpillar

$138.07

2.87 (2.12%)

BSX

Boston Scientific

$42.80

0.3 (0.71%)

NOC

Northrop Grumman

$324.01

0.93 (0.29%)

GD

General Dynamics

$185.92

1.295 (0.70%)

VFC

VF Corp.

$88.25

1.41 (1.62%)

APH

Amphenol

$98.36

1.185 (1.22%)

HLT

Hilton

$95.18

1.95 (2.09%)

FCX

Freeport McMoRan

$11.65

0.16 (1.39%)

SC

Santander Consumer

$25.74

0.49 (1.94%)

KNX

Knight-Swift

$37.87

0.9 (2.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 30

    Jul

  • 08

    Aug

  • 06

    Sep

  • 09

    Sep

  • 02

    Oct

  • 30

    Oct

  • 13

    Nov

  • 02

    Dec

COT

Cott Corp.

$12.34

0.05 (0.41%)

20:15
07/23/19
07/23
20:15
07/23/19
20:15
Upgrade
Cott Corp. rating change at Goldman Sachs »

Cott Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 25

    Sep

RARX

RA Pharmaceuticals

$33.58

-2.43 (-6.75%)

20:11
07/23/19
07/23
20:11
07/23/19
20:11
Syndicate
RA Pharmaceuticals 4M share Secondary priced at $32.50 »

Jefferies, BMO Capital,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

CUTR

Cutera

$24.40

0.19 (0.78%)

20:04
07/23/19
07/23
20:04
07/23/19
20:04
Hot Stocks
Cutera gets approval of Brazil's ANVISA for truSculpt »

Cutera announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 13

    Nov

ITCI

Intra-Cellular

$8.18

-3.81 (-31.78%)

19:44
07/23/19
07/23
19:44
07/23/19
19:44
Hot Stocks
Intra-Cellular updates on lumateperone info provided to FDA »

Intra-Cellular Therapies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 27

    Sep

SCHW

Charles Schwab

$43.54

0.38 (0.88%)

19:28
07/23/19
07/23
19:28
07/23/19
19:28
Periodicals
Charles Schwab CMO, EVP of investor services to leave, BI says »

Charles Schwab is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

FB

Facebook

$202.38

0.06 (0.03%)

19:26
07/23/19
07/23
19:26
07/23/19
19:26
Periodicals
Facebook CEO must certify compliance under FTC privacy agreement, WSJ says »

Facebook CEO Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

AXP

American Express

$128.20

2.19 (1.74%)

19:24
07/23/19
07/23
19:24
07/23/19
19:24
Periodicals
AmEx to refund $1.6M after finding salespeople misrepresented pricing, WSJ says »

American Express is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

OBE

Obsidian Energy

$1.00

0.0087 (0.88%)

19:22
07/23/19
07/23
19:22
07/23/19
19:22
Hot Stocks
Obsidian Energy regains compliance with NYSE listing standards »

Obsidian Energy received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEFT

Euronet

$165.34

1.22 (0.74%)

19:16
07/23/19
07/23
19:16
07/23/19
19:16
Earnings
Breaking Earnings news story on Euronet »

Euronet Worldwide sees Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 12

    Aug

  • 25

    Sep

  • 14

    Nov

EEFT

Euronet

$165.34

1.22 (0.74%)

19:16
07/23/19
07/23
19:16
07/23/19
19:16
Earnings
Euronet Worldwide reports Q2 adjusted EPS $1.69, consensus $1.69 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 12

    Aug

  • 25

    Sep

  • 14

    Nov

CALX

Calix

$7.30

0.155 (2.17%)

19:13
07/23/19
07/23
19:13
07/23/19
19:13
Earnings
Calix sees Q3 adjusted EPS 2c-6c, consensus 10c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

CALX

Calix

$7.30

0.155 (2.17%)

19:12
07/23/19
07/23
19:12
07/23/19
19:12
Earnings
Calix reports Q2 adjusted EPS (1c), consensus (3c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

WE

We Company

$0.00

(0.00%)

19:06
07/23/19
07/23
19:06
07/23/19
19:06
Periodicals
WeWork eyes September IPO, WSJ reports »

WeWork Companies is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIC

Eagle Point Income Company

$0.00

(0.00%)

19:03
07/23/19
07/23
19:03
07/23/19
19:03
Syndicate
Eagle Point Income Company 1.2M share IPO priced at $19.89 »

National Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTS

Tile Shop

$3.08

-0.88 (-22.22%)

18:57
07/23/19
07/23
18:57
07/23/19
18:57
Downgrade
Tile Shop rating change at Telsey Advisory »

Tile Shop downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

AAPL

Apple

$208.85

1.64 (0.79%)

, GOOG

Alphabet

$1,146.62

8.53 (0.75%)

18:57
07/23/19
07/23
18:57
07/23/19
18:57
Periodicals
Apple, Google, Facebook, others petition FCC over VLP Wi-Fi category, Verge says »

Apple (AAPL), Google…

AAPL

Apple

$208.85

1.64 (0.79%)

GOOG

Alphabet

$1,146.62

8.53 (0.75%)

GOOGL

Alphabet Class A

$1,148.77

9.25 (0.81%)

MSFT

Microsoft

$139.29

0.88 (0.64%)

FB

Facebook

$202.38

0.06 (0.03%)

HPQ

HP Inc.

$21.64

0.2 (0.93%)

QCOM

Qualcomm

$74.10

-1.83 (-2.41%)

INTC

Intel

$51.76

0.4 (0.78%)

AVGO

Broadcom

$300.79

4.68 (1.58%)

MRVL

Marvell

$26.50

0.64 (2.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 03

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 27

    Oct

JNCE

Jounce Therapeutics

$4.10

-0.1 (-2.38%)

, TER

Teradyne

$48.09

1.26 (2.69%)

18:56
07/23/19
07/23
18:56
07/23/19
18:56
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Jounce…

JNCE

Jounce Therapeutics

$4.10

-0.1 (-2.38%)

TER

Teradyne

$48.09

1.26 (2.69%)

EW

Edwards Lifesciences

$195.47

1.55 (0.80%)

MANH

Manhattan Associates

$72.91

1.16 (1.62%)

SNAP

Snap

$14.85

0.71 (5.02%)

TXN

Texas Instruments

$120.05

1.89 (1.60%)

OLBK

Old Line Bancshares

$26.14

(0.00%)

CSL

Carlisle

$132.30

2.445 (1.88%)

CMG

Chipotle

$740.42

-1.88 (-0.25%)

CNI

Canadian National

$91.05

-0.07 (-0.08%)

DFS

Discover

$84.54

2.205 (2.68%)

NAVI

Navient

$13.71

0.27 (2.01%)

WFC

Wells Fargo

$47.20

0.7 (1.51%)

IRBT

iRobot

$89.64

-2.7 (-2.92%)

RHI

Robert Half

$58.81

1.45 (2.53%)

V

Visa

$180.89

0.34 (0.19%)

SGEN

Seattle Genetics

$75.88

-0.22 (-0.29%)

FB

Facebook

$202.38

0.06 (0.03%)

TWTR

Twitter

$37.90

0.32 (0.85%)

AMZN

Amazon.com

$1,994.44

8.51 (0.43%)

GOOG

Alphabet

$1,146.62

8.53 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 03

    Aug

  • 08

    Aug

  • 21

    Aug

  • 04

    Sep

  • 05

    Sep

  • 09

    Sep

  • 11

    Sep

  • 23

    Sep

  • 25

    Sep

  • 12

    Oct

  • 15

    Oct

  • 27

    Oct

  • 13

    Nov

  • 24

    Jul

DB

Deutsche Bank

$7.95

0.16 (2.05%)

18:45
07/23/19
07/23
18:45
07/23/19
18:45
Periodicals
Deutsche Bank's credit derivatives seen as hard to offload, Reuters says »

Three bank insiders have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Jul

NHI

National Health Investors

$79.63

0.91 (1.16%)

18:35
07/23/19
07/23
18:35
07/23/19
18:35
Hot Stocks
National Health Investors to invest $7.6M in Colorado community »

National Health Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

RGLS

Regulus

$1.13

-0.07 (-5.83%)

18:32
07/23/19
07/23
18:32
07/23/19
18:32
Hot Stocks
Regulus announces a program update for RGLS4326 »

Regulus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

MPW

Medical Properties Trust

$17.67

0.12 (0.68%)

18:26
07/23/19
07/23
18:26
07/23/19
18:26
Upgrade
Medical Properties Trust rating change at Stifel »

Medical Properties Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAS

Hasbro

$119.22

10.68 (9.84%)

18:24
07/23/19
07/23
18:24
07/23/19
18:24
Hot Stocks
Hasbro CEO: We have a great management team »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.